Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Gut 2006;55:905
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spiller, R.
Right arrow Articles by Watson, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Spiller, R.
Right arrow Articles by Watson, A.
Topic Collections
Right arrowRelated Articles

Digest

Robin Spiller, Alastair Watson, Editor and Deputy Editor

The first 150 words of the full text of this article appear below.


POST INFLAMMATORY VISCERAL HYPERSENSITIVITY DEPENDS ON NERVE GROWTH FACTORS AND THE SENSORY NEUROPEPTIDE CGRP
Visceral hypersensitivity is a common feature of functional diseases, with a variable central and/or peripheral component. Colitis induced by the installation of trinitrobenzene sulfonic acid (TNBS) is a frequently used model of peripherally driven hypersensitivity. Antibodies to nerve growth factor are known to inhibit post inflammatory hypersensitivity in both visceral and somatic territories. Calcitonin gene related peptide (CGRP) is expressed in visceral afferents and increased in TNBS colitis. This study used antibodies to nerve growth factor (NGF), brain derived nerve growth factor (BDNF), and antagonists to CGRP to examine their role in visceral hypersensitivity. TNBS induced a visceral hypersensitivity which was blocked by BDNF antibodies and mimicked in a dose-dependent fashion by intraperitonally injected BDNF. This hypersensitivity could be inhibited by a CGRP antagonist, leading the authors to conclude that both NGF and BDNF are key mediators of hyperalgesic effect of inflammation and act through CGRP as a final common . . . [Full text of this article]


Related Articles

Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat
L Delafoy, A Gelot, D Ardid, A Eschalier, C Bertrand, A M Doherty, and L Diop
Gut 2006 55: 940-945. [Abstract] [Full Text] [PDF]

Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer
H Furukawa, H Ikuma, A Seki, K Yokoe, S Yuen, T Aramaki, and S Yamagushi
Gut 2006 55: 1007-1011. [Abstract] [Full Text] [PDF]

Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study
A Bourreille, M Jarry, P N D’Halluin, E Ben-Soussan, V Maunoury, P Bulois, S Sacher-Huvelin, K Vahedy, E Lerebours, D Heresbach, J F Bretagne, J F Colombel, and J P Galmiche
Gut 2006 55: 978-983. [Abstract] [Full Text] [PDF]

Hepatic venous dysregulation contributes to blood volume pooling in cirrhotic rats
Y Li, H Liu, S A Gaskari, D-M McCafferty, and S S Lee
Gut 2006 55: 1030-1035. [Abstract] [Full Text] [PDF]

Cancer risks in LKB1 germline mutation carriers
H Mehenni, N Resta, J-G Park, M Miyaki, G Guanti, and M C Costanza
Gut 2006 55: 984-990. [Abstract] [Full Text] [PDF]

Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients
K Bodger, J Halfvarson, A R Dodson, F Campbell, S Wilson, R Lee, E Lindberg, G Järnerot, C Tysk, and J M Rhodes
Gut 2006 55: 973-977. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology